Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SIGY

Sigyn Therapeutics (QB) (SIGY)

Sigyn Therapeutics Inc (QB)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SIGY
DateTimeSourceHeadlineSymbolCompany
01/02/202408:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
31/01/202408:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
12/01/202407:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
09/01/202406:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
13/12/202306:48Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
27/10/202306:23Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
05/10/202308:10Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
20/09/202305:56Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
15/08/202305:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:SIGYSigyn Therapeutics Inc (QB)
08/07/202301:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SIGYSigyn Therapeutics Inc (QB)
09/06/202304:38Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
17/05/202321:15InvestorsHub NewsWireSigyn Therapeutics Discloses "DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES" Patent Submission and Related ImmunePrep™ Trademark ApplicationUSOTC:SIGYSigyn Therapeutics Inc (QB)
16/05/202307:35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
11/05/202307:27Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
01/04/202301:06InvestorsHub NewsWireSigyn Therapeutics Announces Filing of 2022 Annual Report on SEC Form 10-KUSOTC:SIGYSigyn Therapeutics Inc (QB)
31/03/202321:19Edgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
01/03/202307:19Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
24/12/202207:52Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
15/11/202207:51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
15/09/202202:37InvestorsHub NewsWireSigyn Therapeutics Announces First-In-Human Clinical Strategy to Address Inflammation and Endotoxemia in End-Stage Renal Disease PatientsUSOTC:SIGYSigyn Therapeutics Inc (QB)
30/08/202220:09Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
15/08/202220:32Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
03/08/202221:07InvestorsHub NewsWireSigyn Therapeutics to Commence Trading on the OTCQB® Venture ExchangeUSOTC:SIGYSigyn Therapeutics Inc (QB)
23/06/202220:02Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:SIGYSigyn Therapeutics Inc (QB)
23/05/202219:00TipRanksAnalysts Are Bullish on These Healthcare Stocks: Sigyn Therapeutics (SIGY)USOTC:SIGYSigyn Therapeutics Inc (QB)
22/03/202208:29Edgar (US Regulatory)Annual Report (10-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
02/03/202209:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SIGYSigyn Therapeutics Inc (QB)
05/02/202202:48Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SIGYSigyn Therapeutics Inc (QB)
18/12/202100:48InvestorsHub NewsWireSigyn Therapeutics CEO Note: As Omicron Surges, Consider That the First Authorized COVID-19 Therapies Were Not Drugs or VaccinesUSOTC:SIGYSigyn Therapeutics Inc (QB)
13/11/202108:49Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SIGYSigyn Therapeutics Inc (QB)
 Showing the most relevant articles for your search:USOTC:SIGY